AbbVie (0QCV) Share Forecast & Price Target
0QCV Analyst Ratings
0QCV Stock 12 Month Forecast
Average Price Target
$289.95▼(-1.51% Downside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Asad Haider | Goldman Sachs | $294 | hold | -0.14%Downside | Reiterated | 10/30/26 | ||
| David Risinger | Leerink Partners | $279 | buy | -5.23%Downside | Reiterated | 10/29/26 | ||
| Louise Chen | Scotiabank | $320 | buy | 8.69%Upside | Reiterated | 10/29/26 | ||
| David Amsellem | Piper Sandler | $303 | buy | 2.92%Upside | Reiterated | 10/26/26 | ||
| Courtney Breen | Bernstein | $230 | hold | -21.88%Downside | Reiterated | 10/25/26 | ||
| Gary Nachman | Canaccord Genuity | $290 | buy | -1.50%Downside | Reiterated | 10/23/26 | ||
| Trung Huynh | RBC Capital | $280 | buy | -4.89%Downside | Reiterated | 10/22/26 | ||
| Michael Yee | UBS | $275 | hold | -6.59%Downside | Reiterated | 10/22/26 | ||
| Jason Gerberry | Bank of America Securities | $305 | buy | 3.60%Upside | Reiterated | 10/22/26 | ||
| Terence Flynn | Morgan Stanley | $310 | buy | 5.30%Upside | Reiterated | 10/22/26 | ||
| Emily Field | Barclays | $300→$325 | buy | 10.39%Upside | Reiterated | 10/21/26 | ||
| Geoff Meacham | Citi | $260 | hold | -11.69%Downside | Reiterated | 10/20/26 | ||
| Mohit Bansal | Wells Fargo | $300 | buy | 1.90%Upside | Reiterated | 10/15/26 | ||
| Evan Seigerman | BMO Capital | $300 | buy | 1.90%Upside | Reiterated | 10/12/26 | ||
| Carter Gould | Cantor Fitzgerald | $285→$290 | buy | -1.50%Downside | Assigned | 10/08/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Asad Haider | 10/30/26 | $294 | hold | -0.14%Downside | Reiterated | Goldman Sachs | ||
| David Risinger | 10/29/26 | $279 | buy | -5.23%Downside | Reiterated | Leerink Partners | ||
| Louise Chen | 10/29/26 | $320 | buy | 8.69%Upside | Reiterated | Scotiabank | ||
| David Amsellem | 10/26/26 | $303 | buy | 2.92%Upside | Reiterated | Piper Sandler | ||
| Courtney Breen | 10/25/26 | $230 | hold | -21.88%Downside | Reiterated | Bernstein | ||
| Gary Nachman | 10/23/26 | $290 | buy | -1.50%Downside | Reiterated | Canaccord Genuity | ||
| Trung Huynh | 10/22/26 | $280 | buy | -4.89%Downside | Reiterated | RBC Capital | ||
| Michael Yee | 10/22/26 | $275 | hold | -6.59%Downside | Reiterated | UBS | ||
| Jason Gerberry | 10/22/26 | $305 | buy | 3.60%Upside | Reiterated | Bank of America Securities | ||
| Terence Flynn | 10/22/26 | $310 | buy | 5.30%Upside | Reiterated | Morgan Stanley | ||
| Emily Field | 10/21/26 | $300→$325 | buy | 10.39%Upside | Reiterated | Barclays | ||
| Geoff Meacham | 10/20/26 | $260 | hold | -11.69%Downside | Reiterated | Citi | ||
| Mohit Bansal | 10/15/26 | $300 | buy | 1.90%Upside | Reiterated | Wells Fargo | ||
| Evan Seigerman | 10/12/26 | $300 | buy | 1.90%Upside | Reiterated | BMO Capital | ||
| Carter Gould | 10/08/26 | $285→$290 | buy | -1.50%Downside | Assigned | Cantor Fitzgerald |
Best Analysts Covering AbbVie
Copying Carter Gould's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +9.32% per trade.
Copying Evan Seigerman's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.35% per trade.
Copying Carter Gould's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +45.86% per trade.
0QCV Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 53 | 48 | 51 | 50 | 57 |
| Hold | 11 | 10 | 9 | 6 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 64 | 58 | 60 | 56 | 66 |
In the current month, 0QCV has received 57 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. 0QCV average Analyst price target in the past 3 months is 289.95.
0QCV Financial Forecast
0QCV Earnings Forecast
Next quarter’s earnings estimate for 0QCV is $3.91 with a range of $3.85 to $4.18. The previous quarter’s EPS was $3.82. 0QCV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0QCV has Performed in-line its overall industry.
0QCV Sales Forecast
Next quarter’s sales forecast for 0QCV is $18.28B with a range of $17.47B to $18.51B. The previous quarter’s sales results were $17.40B. 0QCV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0QCV has Performed in-line its overall industry.